Form 4: Charles River Labs Director Virginia Wilson Reports Stock and Options Acquisition

Director Virginia Wilson reported acquiring common stock and stock options in Charles River Laboratories on May 13, 2024.

Summary

• On May 13, 2024, Virginia Wilson, a director at Charles River Laboratories International, Inc. (CRL), acquired 559 shares of common stock at a price of $228.41 per share.
• Following this transaction, Wilson directly owns 3,965 shares of CRL common stock.
• Wilson also acquired 1,311 stock options with an exercise price of $228.41, which become exercisable on the earlier of May 13, 2025, or the business day prior to the company's next annual meeting of shareholders.
• These options expire on May 13, 2034.
• The transactions were reported on a Form 4 filing with the SEC on May 15, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing reporting insider transactions. It doesn't inherently convey positive or negative sentiment, but the acquisition of shares and options by a director could be seen as a mildly positive signal.

Positives

• The acquisition of shares and options by a director could be interpreted as a sign of confidence in the company's future prospects.

Future Outlook

The document does not contain any specific forward-looking statements or guidance from the company.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders, allowing investors to assess their confidence in the company's performance.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it indicates a director's investment in the company.

Key Dates